These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31836307)

  • 1. Distinct trajectories in HbA1c are associated with different all-cause mortality and morbidity in newly diagnosed patients with type 2 diabetes.
    Hemo B; Geva D; Shahar DR; Golan R; Heymann AD
    Prim Care Diabetes; 2020 Oct; 14(5):413-419. PubMed ID: 31836307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct trajectories of HbA
    Rathmann W; Schwandt A; Hermann JM; Kuss O; Roden M; Laubner K; Best F; Ebner S; Plaumann M; Holl RW;
    Diabet Med; 2019 Nov; 36(11):1468-1477. PubMed ID: 31392761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten-year hemoglobin A1c trajectories and outcomes in type 2 diabetes mellitus: The Diabetes & Aging Study.
    Laiteerapong N; Karter AJ; Moffet HH; Cooper JM; Gibbons RD; Liu JY; Gao Y; Huang ES
    J Diabetes Complications; 2017 Jan; 31(1):94-100. PubMed ID: 27503405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HbA1c variability predicts cardiovascular complications in type 2 diabetes regardless of being at glycemic target.
    Ceriello A; Lucisano G; Prattichizzo F; La Grotta R; Franzén S; Svensson AM; Eliasson B; Nicolucci A
    Cardiovasc Diabetol; 2022 Jan; 21(1):13. PubMed ID: 35073913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes control: Incidence of acute myocardial infarction and all-cause mortality among patients with 3-6 years' disease duration.
    Reges O; Leibowitz M; Hoshen M; Leventer-Roberts M; Greenland P; Balicer R
    Eur J Prev Cardiol; 2017 Jul; 24(10):1083-1092. PubMed ID: 28387143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Moram CBM; Salles GF
    Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients newly diagnosed with clinical type 2 diabetes mellitus but presenting with HbA1c within normal range: 19-year mortality and clinical outcomes.
    Veloso AG; Siersma V; Heldgaard PE; de Fine Olivarius N
    Prim Care Diabetes; 2013 Apr; 7(1):33-8. PubMed ID: 23041240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic memory and all-cause death in community-based patients with type 2 diabetes: the Fremantle Diabetes Study.
    Davis TM; Chubb SA; Bruce DG; Davis WA
    Diabetes Obes Metab; 2016 Jun; 18(6):598-606. PubMed ID: 26936654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High-Risk Vascular Disease Treated With Statin Therapy.
    Menon V; Kumar A; Patel DR; John JS; Wolski KE; McErlean E; Riesmeyer JS; Weerakkody G; Ruotolo G; Cremer PC; Nicholls SJ; Lincoff AM; Nissen SE
    J Am Heart Assoc; 2020 Jan; 9(1):e014328. PubMed ID: 31852422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Significance of Long-term HbA
    Sheng CS; Tian J; Miao Y; Cheng Y; Yang Y; Reaven PD; Bloomgarden ZT; Ning G
    Diabetes Care; 2020 Jun; 43(6):1185-1190. PubMed ID: 32229597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of glycemic control in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials.
    Monami M; Candido R; Pintaudi B; Targher G; Mannucci E;
    Nutr Metab Cardiovasc Dis; 2021 Aug; 31(9):2539-2546. PubMed ID: 34158243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral arterial disease and type 2 diabetes: Older patients still exhibit a survival benefit from glucose control.
    Höbaus C; Herz CT; Wrba T; Koppensteiner R; Schernthaner GH
    Diab Vasc Dis Res; 2020; 17(2):1479164120914845. PubMed ID: 32308023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of HbA1c variability on long-term outcomes in patients with heart failure and type 2 diabetes mellitus.
    Gu J; Pan JA; Fan YQ; Zhang HL; Zhang JF; Wang CQ
    Cardiovasc Diabetol; 2018 Jun; 17(1):96. PubMed ID: 29960591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of HbA1c and educational level with risk of cardiovascular events in 32,871 drug-treated patients with Type 2 diabetes: a cohort study in primary care.
    Östgren CJ; Sundström J; Svennblad B; Lohm L; Nilsson PM; Johansson G
    Diabet Med; 2013 May; 30(5):e170-7. PubMed ID: 23350893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considerably decreased risk of cardiovascular disease with combined reductions in HbA1c, blood pressure and blood lipids in type 2 diabetes: Report from the Swedish National Diabetes Register.
    Eeg-Olofsson K; Zethelius B; Gudbjörnsdottir S; Eliasson B; Svensson AM; Cederholm J
    Diab Vasc Dis Res; 2016 Jul; 13(4):268-77. PubMed ID: 27190080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased risk of cardiovascular mortality by strict glycemic control (pre-procedural HbA1c < 6.5%) in Japanese medically-treated diabetic patients following percutaneous coronary intervention: a 10-year follow-up study.
    Funamizu T; Iwata H; Nishida Y; Miyosawa K; Doi S; Chikata Y; Shitara J; Endo H; Wada H; Naito R; Ogita M; Dohi T; Kasai T; Okazaki S; Isoda K; Miyauchi K; Daida H
    Cardiovasc Diabetol; 2020 Feb; 19(1):21. PubMed ID: 32070335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Type 2 Diabetes and All-Cause Hospitalization and Mortality in the UK General Heart Failure Population: Stratification by Diabetic Glycemic Control and Medication Intensification.
    Lawson CA; Jones PW; Teece L; Dunbar SB; Seferovic PM; Khunti K; Mamas M; Kadam UT
    JACC Heart Fail; 2018 Jan; 6(1):18-26. PubMed ID: 29032131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin decreases glycated albumin to glycated haemoglobin ratio in patients with newly diagnosed type 2 diabetes.
    Sumitani S; Morita S; Deguchi R; Hirai K; Mukai K; Utsu Y; Miki S; Sato B; Nakamura H; Kasayama S; Koga M
    Ann Clin Biochem; 2015 Jan; 52(Pt 1):76-81. PubMed ID: 24604630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Good glycaemic control is associated with a better prognosis in breast cancer patients with type 2 diabetes mellitus.
    Chang YL; Sheu WH; Lin SY; Liou WS
    Clin Exp Med; 2018 Aug; 18(3):383-390. PubMed ID: 29572669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visit-to-Visit HbA
    Li S; Nemeth I; Donnelly L; Hapca S; Zhou K; Pearson ER
    Diabetes Care; 2020 Feb; 43(2):426-432. PubMed ID: 31727686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.